DOI: 10.1007/s00259-017-3913-zPages: 822-823

Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse

1. University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Department of Diagnostic Imaging and Nuclear Medicine

2. International Atomic Energy Agency (IAEA), Nuclear Medicine and Diagnostic Imaging Section

Correspondence to:
Roberto C. Delgado Bolton
Email: rbiolton@gmail.com

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Accepted: Dec 10, 2017
  • Online: Jan 14, 2018

Article Tools

eanm
EJNMMI Ad